Optimal blockade of the renin-angiotensin-aldosterone system

被引：13

作者：

Nussberger, Juerg ^{[1
]}

Bohlender, Juergen ^{[2
]}

机构：

[1] CHU Vaudois, Dept Internal Med, Div Angiol & Hypertens, CH-1011 Lausanne, Switzerland

[2] Hop Fribourgeois, Med Clin, CH-1708 Fribourg, Switzerland

来源：

NATURE REVIEWS CARDIOLOGY | 2013年 / 10卷 / 04期

关键词：

ALISKIREN; INHIBITION;

D O I：

10.1038/nrcardio.2013.28

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Inhibition of the renin-angiotensin-aldosterone system (RAAS) is a successful therapy for hypertension, heart failure, and renal insufficiency. Overdosing of RAAS inhibitors is occasionally observed when several agents are used together, and can cause adverse events such as hypotension, hyperkalaemia, and renal failure. We advocate optimal, rather than complete, RAAS blockade. Nussberger, J. & Bohlender, J. Nat. Rev. Cardiol. 10, 183-184 (2013); published online 12 March 2013; doi:10.1038/nrcardio.2013.28

引用

页码：183 / 184

页数：2

共 50 条

[21] The adipose tissue and the involvement of the renin-angiotensin-aldosterone system in cardiometabolic syndrome [J].

Borghi, F. ;

Seva-Pessoa, B. ;

Grassi-Kassisse, D. M. .

CELL AND TISSUE RESEARCH, 2016, 366 (03) :543-548

[22] Dynamic Changes in the Renin-Angiotensin-Aldosterone System and the Beneficial Effects of Renin-Angiotensin-Aldosterone Inhibitors on Spatial Learning and Memory in a Rat Model of Chronic Cerebral Ischemia [J].

Huang, Xinwu ;

Lu, Guozhou ;

Li, Guochun ;

Li, Hua ;

Li, Beihua ;

Yin, Jiazhen ;

Cao, Shousong .

FRONTIERS IN NEUROSCIENCE, 2017, 11

[23] Mechanisms of Impaired Potassium Handling With Dual Renin-Angiotensin-Aldosterone Blockade in Chronic Kidney Disease [J].

Preston, Richard A. ;

Afshartous, David ;

Garg, Dyal ;

Medrano, Sergio ;

Alonso, Alberto B. ;

Rodriguez, Rolando .

HYPERTENSION, 2009, 53 (05) :754-U28

[24] Paricalcitol counteracts the increased contrast induced nephropathy caused by renin-angiotensin-aldosterone system blockade therapy in a rat model [J].

Sahin, I. ;

Ozkaynak, B. ;

Sar, M. ;

Biter, H. I. ;

Mert, B. ;

Okuyan, E. ;

Kayalar, N. ;

Can, M. M. ;

Gungor, B. ;

Erentug, V. ;

Dinckal, M. H. .

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2014, 18 (19) :2895-2902

[25] Optimal Antagonism of the Renin-Angiotensin-Aldosterone SystemDo We Need Dual or Triple Therapy? [J].

Christian Werner ;

Janine Pöss ;

Michael Böhm .

Drugs, 2010, 70 :1215-1230

[26] Beneficial long-term effect of aldosterone antagonist added to a traditional blockade of the renin-angiotensin-aldosterone system among patients with obesity and proteinuria [J].

Morales, Enrique ;

Gutierrez, Eduardo ;

Caro, Jara ;

Sevillano, Angel ;

Rojas-Rivera, Jorge ;

Praga, Manuel .

NEFROLOGIA, 2015, 35 (06) :554-561

[27] Renin-angiotensin-aldosterone system in the elderly: rational use of aliskiren in managing hypertension [J].

Andersen, Karl .

CLINICAL INTERVENTIONS IN AGING, 2009, 4 :137-151

[28] Impact of inhibitors of the renin-angiotensin-aldosterone system on liver fibrosis and portal hypertension [J].

Tox, U. ;

Steffen, H. M. .

CURRENT MEDICINAL CHEMISTRY, 2006, 13 (30) :3649-3661

[29] The renin-angiotensin-aldosterone system in 2011: role in hypertension and chronic kidney disease [J].

Simoes e Silva, Ana Cristina ;

Flynn, Joseph T. .

PEDIATRIC NEPHROLOGY, 2012, 27 (10) :1835-1845

[30] Stroke, high blood pressure and the renin-angiotensin-aldosterone system - new developments [J].

Atkinson, Jeffrey .

FRONTIERS IN PHARMACOLOGY, 2011, 2

← 1 2 3 4 5 →